Yayınlar & Eserler

Yayın Ağı
Makaleler 10
Tümü (10)
SCI-E, SSCI, AHCI (9)
SCI-E, SSCI, AHCI, ESCI (9)
Scopus (9)
TRDizin (1)

1. Interleukin-40 in Systemic Sclerosis: A Treatment-Sensitive Marker of Immune Modulation Rather Than Disease Activity.

Vasi İ., Bağrıaçık E. Ü., Kardaş R. C., Örüklü N., Yaman M., Yıldırım D., et al.
Clinical and translational science , cilt.19, sa.8, 2026 (SCI-Expanded, Scopus)

2. Microvascular ultrasonography for quantitative evaluation of nailfold vasculature in systemic sclerosis.

Kılıç A. C., Vasi İ., Altay E., Güllüoğlu S., Karaduman İ., Duran R., et al.
BMC medical imaging , cilt.26, sa.1, 2026 (SCI-Expanded, Scopus)

3. Is a variant of uncertain significance always 'insignificant'? A systematic review on PRF1 A91V in Hemophagocytic Lymphohistocytosis and comparative analysis with Still's disease.

Çakır İ. Y., Erden A., Bölek E. Ç., Mulayim M. F., Duran R., Karaduman İ., et al.
Orphanet journal of rare diseases , 2026 (SCI-Expanded, Scopus)

4. Risk of Cancer in Patients With Primary Sjögren's Disease and Their Relatives.

Tuzcu T. U., Karaduman İ., Kardaş R. C., Erden A., Küçük H., Öztürk M. A., et al.
International journal of rheumatic diseases , cilt.29, sa.3, 2026 (SCI-Expanded, Scopus)

5. Assessment of interstitial lung disease in systemic sclerosis using oscillometric methods: a novel approach to respiratory assessment

Vasi İ., Karaduman İ., Alacaoğlu Ş., Duygulu S., Kardaş R. C., Yıldırım D., et al.
RHEUMATOLOGY , cilt.65, sa.1, 2026 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. Lupus and IgA nephropathy: coexistence or coincident?

Duran R., Yıldırım D., Can Kardaş R., Vasi İ., Kaya B., Çakır Y., et al.
Wiener klinische Wochenschrift , cilt.137, sa.19-20, ss.628-634, 2025 (SCI-Expanded, Scopus)

7. Between diffuse and limited: the unique identity of systemic sclerosis–overlap syndromes

KÜÇÜK H., VASİ İ., KARADUMAN İ., ERDEN A.
Anatolian Current Medical Journal , cilt.7, sa.6, ss.913-918, 2025 (TRDizin)

8. NEUTROPHIL ELASTASE AS A MARKER OF NETosis IN IgG4-RELATED DISEASE AND SJÖGREN'S SYNDROME

Cimen Y., Kardas R. C., Yildirim D., Vasi I., SEREZ KAYA B., Duran R., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.84, 2025 (SCI-Expanded, Scopus)

9. EVALUATION OF MITOCHONDRIAL DYSFUNCTION USING MT-ATP6 LEVELS IN ANCA-ASSOCIATED VASCULITIS AND IgG4-RELATED DISEASE

Kardas R. C., Vasi I., Yildirim D., Serez Kaya B., Duran R., Çakır İ. Y., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.84, 2025 (SCI-Expanded, Scopus)

10. Evaluation of the Antitumoral Effect of PI3K/AKT/mTOR Pathway Inhibition and Antioxidant Combination on Burkitt Lymphoma Cell Line.

Karaduman İ., Terzi H., Tastemur S., Şencan M.
Current cancer drug targets , 2025 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 8

1. [PS-228] Sistemik lupus eritematozus hastalarında ciddi immün trombositopeni tedavisinin uzun dönem sonuçları; Lupus çalışma grubu verisi

KİMYON G., TEMİZ KARADAĞ D., GÖKÇEN N., ÇEFLE A., AVCU A., ALİBAZ F., et al.
25. ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Türkiye, 12 - 16 Kasım 2025, cilt.17, ss.338-339, (Özet Bildiri)

2. POS0583 IL-40: A NOVEL PROINFLAMMATORY B CELL-ASSOCIATED CYTOKINE AND ITS ROLE IN SYSTEMIC SCLEROSIS

Vasi İ., Bağrıaçık E. Ü., Kardaş R. C., Örüklü Demir N., Yaman M., Karakuş R., et al.
European Congress of Rheumatology-EULAR 2025, Barcelona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.783-784, (Özet Bildiri)

3. NEUTROPHIL ELASTASE AS A MARKER OF NETosis IN IgG4-RELATED DISEASE AND SJÖGREN'S SYNDROME

Çimen Y., Kardaş R. C., Yıldırım D., Vasi İ., Kaya B., Duran R., et al.
European Congress of Rheumatology, Barcelona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.1117, (Özet Bildiri)

4. ABS0933 EVALUATION OF MITOCHONDRIAL DYSFUNCTION USING MT-ATP6 LEVELS IN ANCA-ASSOCIATED VASCULITIS AND IgG4-RELATED DISEASE

KARDAŞ R. C., VASİ İ., YILDIRIM D., KAYA B., DURAN R., ÇAKIR İ. Y., et al.
European Congress of Rheumatology-EULAR 2025, Barselona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.1532-1533, (Özet Bildiri)

5. EVALUATION OF MITOCHONDRIAL DYSFUNCTION USING MT-ATP6 LEVELS IN ANCA-ASSOCIATED VASCULITIS AND IgG4-RELATED DISEASE

Kardaş R. C., Vasi İ., Yıldırım D., Kaya B., Duran R., Karaduman İ., et al.
European Congress of Rheumatology, Barcelona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.1532-1533, (Özet Bildiri)

6. ABS0495 THE RHEUMATIC DISEASE COMORBIDITY INDEX (RDCI) AS A PREDICTOR OF DISEASE SEVERITY AND RENAL INVOLVEMENT IN ANCA-ASSOCIATED VASCULITIS

GÖKHAN N. S., KARDAŞ R. C., KARADUMAN İ., VASİ İ., YILDIRIM D., KAYA B., et al.
European Congress of Rheumatology-EULAR 2025, Barselona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.2367-2368, (Özet Bildiri)

7. POS1084 Neutrophil Elastase as a Marker of NETosis in IgG4-Related Disease and Sjögrens Syndrome

Çimen Y., KARDAŞ R. C., YILDIRIM D., VASİ İ., KAYA B., DURAN R., et al.
European Congress of Rheumatology-EULAR 2025, Barselona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.1177, (Özet Bildiri)

8. POS1103 ASSESSMENT OF RESPIRATORY PHYSIOLOGY VIA OSCILLOMETRIC METHODS IN THE MONITORING OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH SYSTEMIC SCLEROSIS

VASİ İ., KARDAŞ R. C., DUYGULU S., KAYA B., YILDIRIM D., DURAN R., et al.
European Congress of Rheumatology-EULAR 2025, Barselona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.1190, (Özet Bildiri)
Metrikler

Yayın

18

Yayın (WoS)

9

Yayın (Scopus)

9

Atıf (WoS)

2

H-İndeks (WoS)

1

Atıf (Scopus)

1

H-İndeks (Scopus)

1
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER